Lerdelimumab, CAS 285985-06-0

Product Description: Lerdelimumab (CAT-152) is an IgG4 human anti-TGF-β2 recombinant monoclonal antibody. Lerdelimumab can be used as an anti-scarring agent for glaucoma research[1][2].

Applications: Neuroscience-Neuromodulation

Formula: N/A

References: [1]Mead AL, et al. Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery. Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3394-401./[2]Wormstone IM, et al. TGF-beta2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Invest Ophthalmol Vis Sci.

CAS Number: 285985-06-0

Molecular Weight: N/A

Research Area: Neurological Disease

Solubility: 10 mM in DMSO

Target: TGF-beta/Smad

• SKU: MEXHY-P99695-0
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99695-0
• Package Unit: Get quote
• Quantity Unit: STK
• Conjugate: Unconjugated